← Back
Data updated: Mar 29, 2026
HUMANWELL
Oncology
Generics
HUMANWELL is a generic drug manufacturer focused on Oncology.
2024
Since
2
Drugs
-
Trials
108
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
0 drugs Phase 1: 2
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Active (0)
Discontinued (1)
Company Info
- First Approval
- 2024-02-26
- Latest
- 2026-01-27
- Applications
- 2